LPCN

Lipocine Inc.

NASDAQHealthcareBiotechnologyUS

USD2.19

+0.04 (+1.86%)

Rating:C

Company Profile

CEO

Mahesh V. Patel

IPO Date

2013-10-22

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$2.19

Prev. Close

$2.15

Day Low

$2.19

Day High

$2.23

52W Low

$1.81

52W High

$12.37

Market Cap

$0.01B

Volume

0.02M

News SentimentBullish

Articles

Avg Positive

28.6%

Avg Negative

12.3%

Avg Neutral

59.0%

News Feed

Lipocine Stock Jumps On Litigation Settlement With Clarus Therapeutics

Benzinga·7/15/2021·↑ positive

Lipocine Announces Settlement With Clarus Therapeutics

PRNewsWire·7/14/2021·↑ positive

Lipocine To Present At The Ladenburg Thalmann Healthcare Conference

PRNewsWire·7/6/2021·↑ positive